Tieshan L. Teng

Kaifeng, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Emerging targeted therapies for chronic obstructive pulmonary disease: from symptom control to precision medicine.

Emerging targeted therapies for chronic obstructive pulmonary disease: from symptom control to precision medicine.

Journal: Frontiers in pharmacology

Published: June 17, 2026

Isolation of a Novel Lytic Pseudomonas aeruginosa Phage Henu5 and Fitness Costs of Phage-Driven Resistance.

Isolation of a Novel Lytic Pseudomonas aeruginosa Phage Henu5 and Fitness Costs of Phage-Driven Resistance.

Journal: Microbial biotechnology

Published: March 28, 2026

Characterization of the bacteriophage vB_KpnP_Henu1_3 lytic for K1 Klebsiella pneumoniae and its therapeutic efficacy in Galleria mellonella larvae and mice.

Characterization of the bacteriophage vB_KpnP_Henu1_3 lytic for K1 Klebsiella pneumoniae and its therapeutic efficacy in Galleria mellonella larvae and mice.

Journal: Microbiology spectrum

Published: January 06, 2026

Phage Henu12-resistant mutant derives fitness trade-offs in Shigella dysenteriae.

Phage Henu12-resistant mutant derives fitness trade-offs in Shigella dysenteriae.

Journal: Microbiology spectrum

Published: October 27, 2025

Characterization of bacteriophage Henu4_2 lytic for Escherichia coli and its therapeutic efficacy in infection models.

Characterization of bacteriophage Henu4_2 lytic for Escherichia coli and its therapeutic efficacy in infection models.

Journal: Virology

Published: October 07, 2025

Phage Henu15-resistant mutant derives fitness trade-offs in Morganella morganii.

Phage Henu15-resistant mutant derives fitness trade-offs in Morganella morganii.

Journal: AMB Express

Published: September 24, 2025

Evaluating Proteus mirabilis phage vB_PmiA_PM1 efficacy against catheter-associated urinary tract infections in artificial urine and laboratory media.

Evaluating Proteus mirabilis phage vB_PmiA_PM1 efficacy against catheter-associated urinary tract infections in artificial urine and laboratory media.

Journal: BMC microbiology

Published: September 09, 2025

Evaluating Proteus mirabilis phage vB_PmiA_PM1 efficacy against catheter-associated urinary tract infections in artificial urine and laboratory media.

Evaluating Proteus mirabilis phage vB_PmiA_PM1 efficacy against catheter-associated urinary tract infections in artificial urine and laboratory media.

Journal: BMC microbiology

Published: September 09, 2025

Phage therapy for intestinal infections: efficacy, challenges, and future directions in translational research.

Phage therapy for intestinal infections: efficacy, challenges, and future directions in translational research.

Journal: Frontiers in microbiology

Published: July 24, 2025

Characterization and genomics of phage Henu2_3 against K1 Klebsiella pneumoniae and its efficacy in animal models.

Characterization and genomics of phage Henu2_3 against K1 Klebsiella pneumoniae and its efficacy in animal models.

Journal: AMB Express

Published: May 30, 2025

The virulent bacteriophage Henu8 as an antimicrobial synergist against Escherichia coli.

The virulent bacteriophage Henu8 as an antimicrobial synergist against Escherichia coli.

Journal: Microbiology spectrum

Published: May 16, 2025

Synergistic efficacy of phage Henu10 with antibiotics against Shigella dysenteriae with insight into phage resistance and fitness trade-offs.

Synergistic efficacy of phage Henu10 with antibiotics against Shigella dysenteriae with insight into phage resistance and fitness trade-offs.

Journal: Frontiers in cellular and infection microbiology

Published: September 20, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026